Abstract
Adeno-associated virus (AAV) vectors have been widely adopted for use in gene therapy. A new study raises concerns regarding this approach, reporting that chromosomal insertions of AAV serotype 2 seem to activate proto-oncogenes in human hepatocellular carcinoma.
Original language | English (US) |
---|---|
Pages (from-to) | 1104-1105 |
Number of pages | 2 |
Journal | Nature genetics |
Volume | 47 |
Issue number | 10 |
DOIs | |
State | Published - Sep 29 2015 |
ASJC Scopus subject areas
- Genetics